NCT05212558

Brief Summary

This study was designed to assess the effect of inspiratory and expiratory muscle training in the same cycle on respiratory muscle strength, pulmonary functions, perception of asthma symptoms in children with bronchial asthma. Fifty-one children with bronchial asthma were randomly allocated to the unloaded respiratory muscle training (Placebo training group; n = 17), inspiratory muscle training alone (inspiratory muscle training group; n = 17), or combined inspiratory and expiratory muscle training in the same cycle (combined training group; n = 17). All groups were assessed for respiratory muscle strength, pulmonary functions, and asthma symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 2, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 3, 2022

Completed
25 days until next milestone

First Posted

Study publicly available on registry

January 28, 2022

Completed
Last Updated

January 28, 2022

Status Verified

January 1, 2022

Enrollment Period

1.2 years

First QC Date

January 3, 2022

Last Update Submit

January 14, 2022

Conditions

Keywords

Chronic Respiratory DiseasesRespiratory TherapyChest PhysiotherapyPulmonary FunctionsAsthmaRespiratory Muscle Training

Outcome Measures

Primary Outcomes (5)

  • Inspiratory muscle strength

    Inspiratory muscle strength was assessed by measuring the maximal inspiratory pressure (reflects the strength of the diaphragm and other inspiratory muscles) using an electronic respiratory pressure meter, according to the American Thoracic Society and European Respiratory Society standards. The highest value of three acceptable trials was documented and used for the subsequent analysis. The percent predicted maximal inspiratory pressure values (%) were calculated and used for statistical analysis.

    2 months

  • Expiratory muscle strength

    Expiratory muscle strength was assessed by measuring the maximal expiratory pressure (reflects the strength of the abdominal muscles and other expiratory muscles) using an electronic respiratory pressure meter, according to the American Thoracic Society and European Respiratory Society standards. The highest value of three acceptable trials was documented and used for the subsequent analysis. The percent predicted maximal inspiratory pressure values (%) were calculated and used for statistical analysis.

    2 months

  • Forced vital capacity

    Forced vital capacity, which is the amount of air that each participant was able to forcibly exhale from his/her lungs after taking the deepest breath they can, was measured in a pulmonary function test with a spirometry analyzer and expressed as a percentage of predicted values (%). Three trials were allowed and the best results were recorded.

    2 months

  • Forced expiratory volume in one second

    Forced expiratory volume in one second, which is the volume of air exhaled in the first second during forced exhalation after a maximal inspiration, was measured in a pulmonary function test with a spirometry analyzer and expressed as a percentage of predicted values (%). Three trials were allowed and the best results were recorded.

    2 months

  • Forced expiratory volume in one second / forced vital capacity

    Forced expiratory volume in one second / forced vital capacity, is the ratio of the forced expiratory volume in the first one second to the forced vital capacity of the lungs.

    2 months

Secondary Outcomes (1)

  • Asthma symptoms

    2 months

Study Arms (3)

Placebo group

PLACEBO COMPARATOR

This group received a conventional respiratory retraining program plus unloaded (placebo) respiratory muscle training

Other: Placebo respiratory muscle training

Inspiratory muscle training group

ACTIVE COMPARATOR

This group received a conventional respiratory retraining program plus inspiratory muscle training only

Other: Inspiratory muscle training

Combined training group

EXPERIMENTAL

This group received a conventional respiratory retraining program plus inspiratory and expiratory muscle training in the same respiratory cycle.

Other: Combined inspiratory and expiratory muscle training

Interventions

Unloaded respiratory muscle training plus conventional respiratory exercises

Placebo group

Inspiratory muscle training plus conventional respiratory exercises

Inspiratory muscle training group

Combined inspiratory and expiratory muscle training in the same respiratory cycle plus conventional respiratory exercises.

Combined training group

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Confirmed diagnosis of asthma according to Global Initiative of Asthma guidelines.
  • Age between 12 and 18 years.
  • Clinically stable asthma.
  • Stable doses of medications in the last three months
  • A percent-predicted value of the peak expiratory flow rate of 60-80%
  • No activity limitation due to asthma

You may not qualify if:

  • Unstable asthma
  • Exacerbation of asthma symptoms
  • History of thoracic surgery
  • Cognitive/behavioral problems
  • Cardiopulmonary co-morbidities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ragab K. Elnaggar

Al Kharj, Riyadh Region, Saudi Arabia

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Ragab K Elnaggar, PhD

    Prince Sattam Bin Abdulaziz University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor was blinded to the treatment allocation
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: A randomized, placebo-controlled, assessor-blinded clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 3, 2022

First Posted

January 28, 2022

Study Start

August 2, 2020

Primary Completion

October 28, 2021

Study Completion

October 28, 2021

Last Updated

January 28, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations